NACDS Applauds Sen. Crapo’s Bipartisan Approach to Reducing Patients’ Drug Costs and Protecting Their Freedom of Pharmacy Leadership role on a key committee helps to confront “pharmaceutical benefit manipulation” by “PBM” middlemen

2023-08-08T13:42:46-04:00Categories: Press Release|Tags: , , , , |

Sen. Crapo is leading a press conference in Twin Falls, ID, on addressing PBM practices that have grown increasingly complex and opaque in recent years at the expense of patients and taxpayers.

NACDS Praises Senate Introduction of Bipartisan Legislation Helping to Preserve Medicare Pharmacy Access

2023-07-27T14:26:00-04:00Categories: Press Release|Tags: , , , , , |

NACDS is applauding today the introduction of bipartisan legislation in the U.S. Senate (S. 2477 - the Equitable Community Access to Pharmacist Services Act) that would help maintain the post-pandemic pharmacy access that Americans rely on and expect.

NACDS Lauds Senate Finance Committee for Bipartisan Efforts to Deliver Real and Comprehensive PBM Reform that is Meaningful for Patients and Pharmacies Looks forward to continuing work with leaders in the U.S. Congress to address the “pharmaceutical benefit manipulation” that harms the most vulnerable in the Medicaid and Medicare programs

2023-07-27T11:01:36-04:00Categories: Press Release|Tags: , , , , |

NACDS looks forward to continuing work with leaders in the U.S. Congress to address the “pharmaceutical benefit manipulation” that harms the most vulnerable in the Medicaid and Medicare programs.

National Coalition Applauds Introduction of Senate Legislation to Ensure Senior Access to Prompt Pharmacist Care and Services More Than 190 Organizations Support S. 2447 to Provide Payment for Pharmacist Services for COVID-19, Flu, Strep, and RSV Under Medicare Part B

2023-07-26T15:43:52-04:00Categories: Press Release|Tags: , , , , , |

More Than 190 Organizations Support S. 2447 to Provide Payment for Pharmacist Services for COVID-19, Flu, Strep, and RSV Under Medicare Part B.

NACDS to the U.S. Congress: Real PBM Reform Must Include Medicare and Medicaid A newly released NACDS video urges this message ahead of a July 26 legislative markup scheduled by the U.S. Senate Committee on Finance

2023-07-25T09:58:47-04:00Categories: Press Release|Tags: , , , , |

A newly released NACDS video urges this message ahead of a July 26 legislative markup scheduled by the U.S. Senate Committee on Finance.

Roxanne Fox, JD, Joins NACDS as Vice President of Human Resources and Administration Anderson: “The vibrance and culture of the staff team align with NACDS’ mission and Roxanne is committed to sustaining and advancing NACDS’ extremely strong reputation”

2023-07-24T10:01:45-04:00Categories: Press Release|Tags: |

Anderson: “The vibrance and culture of the staff team align with NACDS’ mission and Roxanne is committed to sustaining and advancing NACDS’ extremely strong reputation”.

NACDS Commends Senate Finance Committee for Scheduling PBM Reform Bill Markup, Pledges Engagement for Real PBM Reform That Addresses Needs of Medicare and Medicaid Patients and Their Pharmacies “S. 1038 and S. 2052 are vital for real PBM reform, and for addressing ‘pharmaceutical benefit manipulation’ that harms the most vulnerable in the Medicaid and Medicare programs.”

2023-07-13T15:30:09-04:00Categories: Press Release|Tags: , , , , |

“S. 1038 and S. 2052 are vital for real PBM reform, and for addressing ‘pharmaceutical benefit manipulation’ that harms the most vulnerable in the Medicaid and Medicare programs.”

NACDS Lauds DIR Fee and Pharmacy Access Bill as Vital for PBM Reform Bill aims to preserve seniors’ freedom of pharmacy choice by confronting tactics that bar pharmacies from Part D networks and drive pharmacies out of business

2023-06-21T14:08:59-04:00Categories: Press Release|Tags: , , , , |

NACDS today praised the bipartisan introduction of the Protect Patient Access to Pharmacies Act (S. 2052) – a bill that would help preserve Medicare beneficiaries’ access to their pharmacy of choice and help stop “pharmaceutical benefit manipulation” that harms patients and pharmacies alike.

Go to Top